Roles of PFKFB3 in cancer L Shi, H Pan, Z Liu, J Xie, W Han Signal transduction and targeted therapy 2 (1), 1-10, 2017 | 243 | 2017 |
LIF negatively regulates tumour-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers H Yu, X Yue, Y Zhao, X Li, L Wu, C Zhang, Z Liu, K Lin, ZY Xu-Monette, ... Nature communications 5 (1), 5218, 2014 | 180 | 2014 |
LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway X Li, Q Yang, H Yu, L Wu, Y Zhao, C Zhang, X Yue, Z Liu, H Wu, BG Haffty, ... Oncotarget 5 (3), 788, 2014 | 166 | 2014 |
Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis W Han, J Xie, L Li, Z Liu, X Hu Apoptosis 14, 674-686, 2009 | 166 | 2009 |
Multiple primary malignant tumors-a clinical analysis of 15,321 patients with malignancies at a single center in China C Zhai, Y Cai, F Lou, Z Liu, J Xie, X Zhou, Z Wang, Y Fang, H Pan, W Han Journal of cancer 9 (16), 2795, 2018 | 114 | 2018 |
Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction X Yue, Y Zhao, C Zhang, J Li, Z Liu, J Liu, W Hu Oncotarget 7 (4), 3777, 2016 | 81 | 2016 |
Inhibiting cancer metastasis via targeting NAPDH oxidase 4 B Zhang, Z Liu, X Hu Biochemical Pharmacology 86 (2), 253-266, 2013 | 74 | 2013 |
Schisandrin B attenuates cancer invasion and metastasis via inhibiting epithelial-mesenchymal transition Z Liu, B Zhang, K Liu, Z Ding, X Hu PloS one 7 (7), e40480, 2012 | 64 | 2012 |
The role of autophagy in colitis-associated colorectal cancer Y Wu, J Yao, J Xie, Z Liu, Y Zhou, H Pan, W Han Signal transduction and targeted therapy 3 (1), 31, 2018 | 59 | 2018 |
Schisandrin B prevents doxorubicin-induced cardiotoxicity via enhancing glutathione redox cycling L Li, Q Pan, W Han, Z Liu, L Li, X Hu Clinical Cancer Research 13 (22), 6753-6760, 2007 | 56 | 2007 |
Schisandrin B prevents doxorubicin-induced chronic cardiotoxicity and enhances its anticancer activity in vivo Y Xu, Z Liu, J Sun, Q Pan, F Sun, Z Yan, X Hu PloS one 6 (12), e28335, 2011 | 53 | 2011 |
Ursolic acid synergistically enhances the therapeutic effects of oxaliplatin in colorectal cancer J Shan, Y Xuan, Q Zhang, C Zhu, Z Liu, S Zhang Protein & Cell 7 (8), 571-585, 2016 | 51 | 2016 |
Prognosis and nomogram for predicting postoperative survival of duodenal adenocarcinoma: a retrospective study in China and the SEER database S Jiang, R Zhao, Y Li, X Han, Z Liu, W Ge, Y Dong, W Han Scientific reports 8 (1), 7940, 2018 | 44 | 2018 |
The efficacy and safety of apatinib treatment for patients with unresectable or relapsed liver cancer: a retrospective study L Zhen, C Jiali, F Yong, X Han, P Hongming, H Weidong Journal of Cancer 9 (16), 2773, 2018 | 42 | 2018 |
Analysis of potential genes and pathways associated with the colorectal normal mucosa–adenoma–carcinoma sequence Z Wu, Z Liu, W Ge, J Shou, L You, H Pan, W Han Cancer medicine 7 (6), 2555-2566, 2018 | 36 | 2018 |
BRAF mutation as a potential therapeutic target for checkpoint inhibitors: a comprehensive analysis of immune microenvironment in BRAF mutated colon cancer S Cen, K Liu, Y Zheng, J Shan, C Jing, J Gao, H Pan, Z Bai, Z Liu Frontiers in Cell and Developmental Biology 9, 705060, 2021 | 25 | 2021 |
Circulating tumor cells predict survival benefit from chemotherapy in patients with lung cancer ZX Wu, Z Liu, HL Jiang, HM Pan, WD Han Oncotarget 7 (41), 67586, 2016 | 23 | 2016 |
Complete genome of Phenylobacterium zucineum – a novel facultative intracellular bacterium isolated from human erythroleukemia cell line K562 Y Luo, X Xu, Z Ding, Z Liu, B Zhang, Z Yan, J Sun, S Hu, X Hu BMC genomics 9, 1-17, 2008 | 22 | 2008 |
Cyclosporine A sensitizes lung cancer cells to crizotinib through inhibition of the Ca2+/calcineurin/Erk pathway Z Liu, L Jiang, Y Li, B Xie, J Xie, Z Wang, X Zhou, H Jiang, Y Fang, H Pan, ... EBioMedicine 42, 326-339, 2019 | 19 | 2019 |
Intestinal epithelial cell autophagy deficiency suppresses inflammation-associated colon tumorigenesis H Liu, J Lou, Y Liu, Z Liu, J Xie, J Sun, H Pan, W Han Molecular Therapy-Nucleic Acids 28, 35-46, 2022 | 11 | 2022 |